Back to Results
First PageMeta Content
Pharmacology / Cyclopropanes / Drospirenone / Lactones / Progestagens / Beyaz / Bayer HealthCare Pharmaceuticals / Medical prescription / Combined oral contraceptive pill / Chemistry / Hormonal contraception / Organic chemistry


Department of Health and Human Services Public Health Service Food and Drug Administration
Add to Reading List

Open Document

File Size: 466,95 KB

Share Result on Facebook

City

Reference / /

Company

Bayer HealthCare Pharmaceuticals Inc. / IMS Health / Encuity Research LLC. / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

outpatient retail pharmacy setting / drospirenone-containing contraceptive products / retail / contraceptive products / /

MedicalTreatment

oral contraceptives / birth control / contraception / Hormone replacement therapy / /

OperatingSystem

OSE / /

Organization

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation / Drug Use Data Analyst Division / office of Surveillance / FDA / Research office of Surveillance and Epidemiology Drug Use Review Date / /

Person

Grace Chai / Judy A. Staffa / Patty Greene / /

Position

contractor / Team Leader / Division Director / EXECUTIVE / Physician / CONTENTS EXECUTIVE / /

Product

Beyaz Drug / levonorgestrel / estradiol / Beyaz prescriptions / Dispensed Prescriptions / Angeliq / Yaz / Yasmin / Loryna® / Gianvi® / Beyaz® / Yaz® / Zarah® / Syeda® / Yasmin® / Vestura® / Dose / Trade Name Safyral® Application Original Number / Ocella® / /

URL

http /

SocialTag